Literature DB >> 21330397

The Woven EndoBridge: a new aneurysm occlusion device.

Y H Ding1, D A Lewis, R Kadirvel, D Dai, D F Kallmes.   

Abstract

BACKGROUND AND
PURPOSE: The WEB device is an intrasaccular ellipsoid braided-wire embolization device designed to provide flow disruption along the aneurysm neck. The purpose of this study was to evaluate, in an in vivo aneurysm model, the acute and chronic performance of the WEB device regarding immediacy, degree, and durability of aneurysm occlusion.
MATERIALS AND METHODS: The WEB device was implanted in 24 elastase-induced aneurysms in New Zealand white rabbits and followed for 1, 3, 6, and 12 months (n = 6 at all time points). Degree of intra-aneurysmal flow disruption was graded on a 4-point scale based on DSA within 10 minutes following device implantation. Chronic aneurysm occlusion was rated by using a 3-point scale. All aneurysms were harvested for histologic analysis.
RESULTS: Immediate postimplant grade 1 (complete flow cessation) was noted in 7 (29%) of 24 cases. Grade 2 (near-complete flow cessation) was noted in 13 (54%) of 24 cases. At follow-up, complete occlusion was noted in 8 (33%) of 24 cases. Near-complete aneurysm occlusion was noted in 14 (58%) of 24 cases, while incomplete occlusion was noted in 2 (8%) cases. Stable aneurysm occlusion was present in 7 (29%) of 24 cases; progressive occlusion, in 14 (58%); and recanalization, in 3 (13%) cases. Histologic findings included aneurysm cavities filled with organized thrombus with connective tissue across the aneurysm neck.
CONCLUSIONS: The WEB device in experimental aneurysms demonstrated promising rates of immediate and long-term aneurysm occlusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21330397      PMCID: PMC8013102          DOI: 10.3174/ajnr.A2399

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  30 in total

1.  1999 ARRS Executive Council Award. Creation of saccular aneurysms in the rabbit: a model suitable for testing endovascular devices. American Roentgen Ray Society.

Authors:  T A Altes; H J Cloft; J G Short; A DeGast; H M Do; G A Helm; D F Kallmes
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

2.  Early fatal hemorrhage after endovascular cerebral aneurysm treatment with a flow diverter (SILK-Stent): do we need to rethink our concepts?

Authors:  Bernd Turowski; Stephan Macht; Zolt Kulcsár; Daniel Hänggi; Walter Stummer
Journal:  Neuroradiology       Date:  2010-03-26       Impact factor: 2.804

3.  Endovascular treatment of intracranial aneurysms: comparative evaluation in a terminal bifurcation aneurysm model in dogs.

Authors:  Yoshikazu Yoshino; Yasunari Niimi; Joon K Song; Michael Silane; Alejandro Berenstein
Journal:  J Neurosurg       Date:  2004-12       Impact factor: 5.115

4.  Endovascular reconstruction with the Neuroform stent as monotherapy for the treatment of uncoilable intradural pseudoaneurysms.

Authors:  David Fiorella; Felipe C Albuquerque; Vivek R Deshmukh; Henry H Woo; Peter A Rasmussen; Thomas J Masaryk; Cameron G McDougall
Journal:  Neurosurgery       Date:  2006-08       Impact factor: 4.654

5.  Buenos Aires experience with the Neuroform self-expanding stent for the treatment of intracranial aneurysms.

Authors:  Pedro Lylyk; Angel Ferrario; Boris Pasbón; Carlos Miranda; Gustavo Doroszuk
Journal:  J Neurosurg       Date:  2005-02       Impact factor: 5.115

6.  Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system.

Authors:  M Hayakawa; Y Murayama; G R Duckwiler; Y P Gobin; G Guglielmi; F Viñuela
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

7.  Endovascular treatment of experimental aneurysms by use of fibroblast-coated platinum coils: an angiographic and histopathologic study.

Authors:  Daying Dai; Yong Hong Ding; Mark A Danielson; Ramanathan Kadirvel; Larry W Hunter; Wen-Zhi Zhan; Gregory A Helm; Debra A Lewis; Harry J Cloft; Gary C Sieck; David F Kallmes
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

8.  Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms.

Authors:  D Fiorella; P Lylyk; I Szikora; M E Kelly; F C Albuquerque; C G McDougall; P K Nelson
Journal:  J Neurointerv Surg       Date:  2009-06-16       Impact factor: 5.836

9.  Effect of flow diverter porosity on intraaneurysmal blood flow.

Authors:  Luca Augsburger; Mohamed Farhat; Philippe Reymond; Edouard Fonck; Zsolt Kulcsar; Nikos Stergiopulos; Daniel A Rüfenacht
Journal:  Klin Neuroradiol       Date:  2009-08-23

10.  Endovascular treatment of experimental aneurysms with use of fibroblast transfected with replication-deficient adenovirus containing bone morphogenetic protein-13 gene.

Authors:  D Dai; Y H Ding; M A Danielson; R Kadirvel; G A Helm; D A Lewis; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-09       Impact factor: 3.825

View more
  48 in total

1.  The Woven EndoBridge device for ruptured intracranial aneurysms: international multicenter experience and updated meta-analysis.

Authors:  Pablo Harker; Robert W Regenhardt; Naif M Alotaibi; Justin Vranic; Faith C Robertson; Adam A Dmytriw; Jerry C Ku; Matthew Koch; Christopher J Stapleton; Thabele M Leslie-Mazwi; Nelson Serna; Boris Pabon; Juan A Mejia; Aman B Patel
Journal:  Neuroradiology       Date:  2021-05-25       Impact factor: 2.804

2.  A New Aneurysm Occlusion Classification after the Impact of Flow Modification.

Authors:  H S Cekirge; I Saatci
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

Review 3.  From bench to bedside: utility of the rabbit elastase aneurysm model in preclinical studies of intracranial aneurysm treatment.

Authors:  Waleed Brinjikji; Yong H Ding; David F Kallmes; Ramanathan Kadirvel
Journal:  J Neurointerv Surg       Date:  2015-04-22       Impact factor: 5.836

4.  WEB-DL endovascular treatment of wide-neck bifurcation aneurysms: short- and midterm results in a European study.

Authors:  B Lubicz; J Klisch; J-Y Gauvrit; I Szikora; M Leonardi; T Liebig; N P Nuzzi; E Boccardi; F D Paola; M Holtmannspötter; W Weber; E Calgliari; V Sychra; B Mine; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-23       Impact factor: 3.825

5.  WEB device for endovascular treatment of wide-neck bifurcation aneurysms.

Authors:  B Lubicz; B Mine; L Collignon; D Brisbois; G Duckwiler; C Strother
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-04       Impact factor: 3.825

6.  Image-based modeling of blood flow in cerebral aneurysms treated with intrasaccular flow diverting devices.

Authors:  Fernando Mut; Bong Jae Chung; Jorge Chudyk; Pedro Lylyk; Ramanathan Kadirvel; David F Kallmes; Juan R Cebral
Journal:  Int J Numer Method Biomed Eng       Date:  2019-04-11       Impact factor: 2.747

7.  The Woven EndoBridge cerebral aneurysm embolization device (WEB II): initial clinical experience.

Authors:  Joachim Klisch; Vojtech Sychra; Christoph Strasilla; Thomas Liebig; David Fiorella
Journal:  Neuroradiology       Date:  2011-05-27       Impact factor: 2.804

8.  Role of C-arm VasoCT in the use of endovascular WEB flow disruption in intracranial aneurysm treatment.

Authors:  J Caroff; C Mihalea; H Neki; D Ruijters; L Ikka; N Benachour; J Moret; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2014-02-13       Impact factor: 3.825

9.  Woven Endobridge (WEB) Device for endovascular treatment of ruptured intracranial wide-neck aneurysms: a single-center experience.

Authors:  Jildaz Caroff; Cristian Mihalea; Francesco Dargento; Hiroaki Neki; Léon Ikka; Nidhal Benachour; Jacques Moret; Laurent Spelle
Journal:  Neuroradiology       Date:  2014-06-15       Impact factor: 2.804

10.  Angiographic C-arm CT visualization of the Woven EndoBridge cerebral aneurysm embolization device (WEB): first experience in an animal aneurysm model.

Authors:  T Struffert; S Lang; E Adamek; T Engelhorn; C M Strother; A Doerfler
Journal:  Clin Neuroradiol       Date:  2013-05-28       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.